07/02/2014
Five Vanderbilt technologies were awarded U.S. patent protection in June. They are:
8,740,762 | Specific inhibition of cPLA.sub.2 enhances the efficacy of radiotherapy |
8,747,345 | Percutaneous collateral bypass |
8,747,801 | Broad-emission nanocrystals and methods of making and using same |
8,748,381 | Compositions and methods for the treatment of disorders involving epithelial cell apoptosis |
8,759,377 | Substituted dioxopiperidines and dioxopyrrolidines as MGLUR4 allosteric potentiators, compositions, and methods of treating neurological dysfunction |